JPH0331181B2 - - Google Patents

Info

Publication number
JPH0331181B2
JPH0331181B2 JP58179341A JP17934183A JPH0331181B2 JP H0331181 B2 JPH0331181 B2 JP H0331181B2 JP 58179341 A JP58179341 A JP 58179341A JP 17934183 A JP17934183 A JP 17934183A JP H0331181 B2 JPH0331181 B2 JP H0331181B2
Authority
JP
Japan
Prior art keywords
toxin
fat globule
fat
gangliosides
ganglioside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58179341A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6072819A (ja
Inventor
Kotaro Takamizawa
Hiroo Takayama
Ryuichiro Tanaka
Toshizo Sakurai
Mitsuo Umada
Masahiko Mutai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP58179341A priority Critical patent/JPS6072819A/ja
Publication of JPS6072819A publication Critical patent/JPS6072819A/ja
Publication of JPH0331181B2 publication Critical patent/JPH0331181B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP58179341A 1983-09-29 1983-09-29 細菌毒素の中和剤 Granted JPS6072819A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58179341A JPS6072819A (ja) 1983-09-29 1983-09-29 細菌毒素の中和剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58179341A JPS6072819A (ja) 1983-09-29 1983-09-29 細菌毒素の中和剤

Publications (2)

Publication Number Publication Date
JPS6072819A JPS6072819A (ja) 1985-04-24
JPH0331181B2 true JPH0331181B2 (enrdf_load_html_response) 1991-05-02

Family

ID=16064144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58179341A Granted JPS6072819A (ja) 1983-09-29 1983-09-29 細菌毒素の中和剤

Country Status (1)

Country Link
JP (1) JPS6072819A (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0685684B2 (ja) * 1986-01-17 1994-11-02 雪印乳業株式会社 ガングリオシド添加粉乳
JPH06122284A (ja) * 1992-01-24 1994-05-06 Nitto Denko Corp 熱転写記録材料の被転写紙
JP2000234001A (ja) 1999-02-16 2000-08-29 Snow Brand Milk Prod Co Ltd ガングリオシド高含有組成物の製造法
JP2007055921A (ja) * 2005-08-23 2007-03-08 Nagasaki Univ ヘリコバクター・ピロリの空胞化毒素に対する結合剤
JP4852684B2 (ja) 2005-09-30 2012-01-11 雪印メグミルク株式会社 乳由来複合脂質高含有粉末

Also Published As

Publication number Publication date
JPS6072819A (ja) 1985-04-24

Similar Documents

Publication Publication Date Title
Allan et al. Preparation and characterization of the plasma membrane of pig lymphocytes
JPS62174023A (ja) 抗血液凝固物質、その製法及びそれを有効成分とする抗血液凝固剤
JP3071669B2 (ja) 抗アレルギー物質、その製造方法、抗アレルギー剤及び機能性食品
EP0385118A2 (en) Use of compounds containing or binding sialic acid to neutralize bacterial toxins
Wu et al. Nature of the Sendai virus receptor: glycoprotein versus ganglioside
JPH0331181B2 (enrdf_load_html_response)
JP3694319B2 (ja) 多量体アルファ−ラクトアルブミンを含有する抗菌組成物
CA1257204A (en) Botulinus toxin neutralizer
WO1997032893A1 (en) Purification method
JP2678653B2 (ja) ガングリオシドの抽出および濃縮方法
AU648800B2 (en) Immune suppressive product
Kahlenberg et al. d-Glucose Uptake by Isolated Human Erythrocyte Membranes versusd-Glucose Transport by Human Erythrocytes: COMPARISON OF THE EFFECTS OF PROTEOLYTIC AND PHOSPHOLIPASE A2 DIGESTION
US5244807A (en) Production of pseudomonas xa cells containing indolyl-3-alkane alpha-hydroxylase
GB2077101A (en) Antiallergic composition containing streptococci
JPH0347200A (ja) マカラスムギ由来の糖タンパク質、その製造法及びそれを含有する免疫調節剤
JP3920933B2 (ja) 血中コレステロール低下剤
JP2821770B2 (ja) 細菌毒素中和能を付与した育児用粉乳
US5039610A (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
JPS6159610B2 (enrdf_load_html_response)
JPH09206025A (ja) ポリアミンの製造方法
JPS597695B2 (ja) 免疫制御作用を有するペプタイド製剤
US3637462A (en) Purification of enzymes
DE69719049T2 (de) Pharmazeutische zusammensetzung, enthaltend komplementproteine, zur behandlung von helicobacter-infektionensowie ein verfahren zur herstellung der zusammensetzung
Smith et al. The Chemical Basis of the Virulence of Bacillus anthracis. VIII: Fractionation of the Intracellular Material of Bacillus anthracis
Nakanishi et al. Induction of autoimmune phenomena in normal mice treated with natural thymocytotoxic autoantibody.